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This in vivo study presents the preliminary results of the use of a novel piezoelectric actuator for orthopedic application. The
innovative use of the converse piezoelectric effect to mechanically stimulate bone was achieved with polyvinylidene fluoride
actuators implanted in osteotomy cuts in sheep femur and tibia. The biological response around the osteotomies was assessed
through histology and histomorphometry in nondecalcified sections and histochemistry and immunohistochemistry in decalcified
sections, namely, throughMasson’s trichrome, and labeling of osteopontin, proliferating cell nuclear antigen, and tartrate-resistant
acid phosphatase. After one-month implantation, total bone area and new bone area were significantly higher around actuators
when compared to static controls. Bone deposition rate was also significantly higher in the mechanically stimulated areas. In
these areas, osteopontin increased expression was observed. The present in vivo study suggests that piezoelectric materials and the
converse piezoelectric effect may be used to effectively stimulate bone growth.
1. Introduction
It is known that bone mass density and architecture are inti-
mately dependent upon mechanical factors. Several in vitro
studies suggest that cell mechanical stimulation promotes
proliferation and differentiation of osteogenic lineage [1, 2],
in agreement with the results from several in vivo studies
[3–5]. Bone remodeling is influenced by strain magnitude,
frequency, and loading duration.
The clinical longevity and success of an implant also
depend on mechanical determinants. Stress shielding causes
bone loss through remodeling due to decreased loading,
particularly in noncemented prostheses [6, 7]. Several so-
lutions have been proposed for these two mechanical
problems, namely, design variations and development of
controlled-stiffness implants [8, 9]. A new approach to this
problem, with potential application to other orthopedic
problems and other medical fields, would be the develop-
ment of smart implants integrating systems for bone me-
chanical stimulation.
The present in vivo study explores the use of the converse
piezoelectric effect to mechanically stimulate bone with
resource to Polyvinylidene Fluoride films (PVDF) (Mea-
surement Specialties Inc Company, USA). These films were
used, after dip-coating to improve cell adhesion and assure
electrical insulation, as a substrate forMC3T3 cells to explore
the concept of using piezoelectric materials and converse
piezoelectric effect to produce effective osteoblast mechanical
stimulation. The coating was performed by dip-coating at
constant velocity of 0,238mm/s. The chosen material for
coating was an acrylic, poly(methyl methacrylate) (PMMA),
(PERFEX, International Dental Products, USA), used alone
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Figure 1: Location of the actuators within the bone. The figure shows example of bone section prior to inclusion: (a) section of tibia—scale
bar 1 cm; (b) shows how the areas for histomorphometry were distributed; Z1 corresponds to the film clamped region—scale bar 2 cm.
in the first three layers and a in forth layer along with 4%
of Bonelike (250–500 µm) particles added (kindly offered by
INESCPorto). The displacement was higher where the cells
were seeded, in the central area of the coated devices, in the
order of 700 nm along the z-axis, in a semisinusoidal fashion.
On the substrates submitted to dynamic conditions, stimula-
tion was done with an alternating sinusoidal current (AC), of
5 V, at 1Hz and 3Hz for 15 minutes at each frequency [10].
In this exploratory in vivo study, the same coating procedures
and daily stimulation regimens were applied. The biological
response around the osteotomies was assessed through
histology and histomorphometry in undecalcified sections,
and through histochemistry and immunohistochemistry in
decalcified sections, namely, through Masson’s trichrome,
and labeling of osteopontin (OPN), proliferating cell nuclear
antigen (PCNA), and tartrate-resistant acid phosphatase
(TRAP).
2. Materials andMethods
2.1. Actuator Device Design and Sterilization. The actuator
device was composed of a microboard containing an ultra-
low power 16-bit microcontroller (eZ430-RF2500, Texas
Instruments, USA), powered by lithium battery and encap-
sulated in PMMA and a set of six actuators composed
of polyvinylidene fluoride (PVDF) and silver electrodes,
electrically insulated by dip-coating as described elsewhere
[10]. Each actuator measured 15mm width and 40mm
length, with an active area of 12 × 31mm2. The actuator
device was programmed to apply a 5V square wave of 1Hz
and 3Hz for 15 minutes at each frequency, once every 24
hours.
Finite Numerical Method studies and Electronic Speckle
Pattern Interferometry Process (ESPI) studies have shown
the lower deformation levels occurred in the clamped region
of the films, for a potential differential of 5 V, and the higher
deformation occurred in the opposite extremity of the film
[10].
A control device, similar but static was also developed. A
sterilization method was developed and validated based on
ISO 11737-1 and ISO 14937, using a series of decontami-
nating solutions (10% sodium hypochlorite for 20 minutes,
without agitation, washing in sterile water, and immersion
in 10% hydrogen peroxide for 30 minutes, without agitation,
followed by rinse in sterile water and drying under laminar
flux), before 2 hours of exposure to UV (in two different
positions).
2.2. Surgical Procedure. The actuator device was implanted
in the left hind limb, and a control device was implanted in
the right hind limb, of a 4-year-old merino ewe, with 45 kg
body-weight.
The animal was premedicated with atropine (0.7mg/kg),
xylazine (0.1mg/kg) and butorphanol (0.01mg/kg), and
anesthesia induced with thiopental sodium 5% (5mg/kg)
by intravenous injection. The anesthesia was maintained
through isoflurane with spontaneous ventilation.
The stifle joint of both legs was prepared with a solution
of povidone-iodine and ethanol 70%, after being shorn
and shaved. Two longitudinal incisions were made on the
craniomedial border of the femur and at tibial crest level.
The tibial bone was exposed by reflecting deep medial fascia,
the vastus medialis and cranial part of the sartorius muscles
and the periosteum, and two osteotomies were made using
an especially metal designed guide to make two regular and
well-orientated osteotomies using an oscillating saw. The
bone was continuously irrigated with a sterile saline solution
during the process of low-speed drilling and cutting. The
same procedure was followed with a different design guide
for the distal femoral physis, where four osteotomies were
done. The osteotomies were made perpendicularly to the
long axis of the bone.
A stab wound was made in the fascia lata, and the
extremities of the piezoelectric films passed through it, and
then, the active area of each piezoelectric film was placed
inside the slot osteotomy cavity. The actuator position inside
the tibial bone can be clearly viewed in Figure 1(a), obtained
post-mortem. The portion of the device containing the
microprocessor and the power supply was left in the nearby
subcutaneous space.
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Figure 2: Postoperative radiograph thirty days after implantation
showing the six actuators in place (four in the femur, two in the
tibia). There are neither signs of periostal or peri-implantar reaction
nor signs of infection in neighboring soft tissues.
The actuator device was implanted in the left hind
limb, and control on the right hind limb. After placing the
implants, incisions were closed routinely with a continuous-
pattern suture in the retinaculum and fascia, using absorba-
ble Surgicryl 2/0 (SMI AG, Belgium) and in the skin with Silk
0 (SMI AG).
Postoperative X-ray images were obtained thirty days
after implantation, before sacrifice, to ensure the proper
evolution of the bone cuts and to detect signs of infection/in-
flammation (Figure 2).
One week after implantation calcein (15mg/kg; Sigma,
USA) was injected subcutaneously and one week prior to
sacrifice the same procedure was done with alizarin complex-
one (25mg/kg; Sigma, USA). Thirty days after implantation,
the ewe was sacrificed by intravenous sodium pentobarbital
injection.
The present study was authorized by competent national
authorities and conducted accordingly to FELASA’s guide-
lines for animal care.
2.3. Tissue Processing, Histology, and Immunohistochemistry.
Both hind limbs were dissected, the implanted materials and
surrounding tissue removed and fixed in 4% paraformalde-
hyde for two weeks. Bone samples were cut transversally to
the long axis of the bone, each including a piezoelectric film
and the surrounding bone (Figure 1(a)).
Specimens were dehydrated through an ascending
ethanol series. Soft tissues (local lymph nodes and samples of
the fibrous capsule surrounding the implants) were routinely
processed and embedded in paraffin. Undecalcified bone
samples of each of the implants were included in resin
(Technovit 9100, Heraeus Kulzer, Germany) according to
the manufacturer’s instructions and 80 µm thick sections
cut with a saw microtome (Leica 1600, Germany) parallel
to the piezoelectric film long axis. A minimum of five
sections of each resin block was cut. Sections were then
appropriately processed for routine staining (Giemsa Eosin),
mounted for fluorescence microscopy. The prepared slides
were evaluated qualitatively. For histomorphometric studies,
the interface between the bone and implant was divided in
four distinct areas: Z1, Z2, Z3, and Z4, from cortical towards
bone surrounding the free extremity of the piezoelectric
film (Figure 1(b)). Pictures were taken from the bone
surrounding both sides of the film in areas Z1 to Z3 and Z4,
using a 40x magnification (Figure 3).
For immunohistochemistry and histochemistry, bone
sections were decalcified in formic acid 5% for 3 weeks,
dehydrated in ethanol, cleared in xylene, and embedded
in paraffin wax and 3 µm sections cut. After deparaffiniza-
tion and rehydration, immunohistochemistry sections were
treated with 3% hydrogen peroxide for 10 minutes. Primary
antibodies for Tartrate-Resistant Acid Phosphatase (TRAP)
(Thermo Scientific, USA, mouse monoclonal antibody, Ab-
1, Clone 26E5, Cat. no.MS-1768), Proliferating Cell Nuclear
Antigen (PCNA) (NeoMarkers, USA, mouse monoclonal
antibody, Ab-1, Clone PC10, Cat. no.MS-106-P0), and
Osteopontin (NeoMarkers, rabbit polyclonal antibody, Cat.
no.RB-9097) were diluted to 1 : 20, 1 : 200, and 1 : 50, respec-
tively. Prior to immunostaining, the sections were pretreated
for antigen retrieval at 100◦C in 10mM citrate buffer, pH 6,
for 20 minutes in microwave oven, followed by cooling for 30
minutes at room temperature. For double staining of PCNA
and osteopontin, immunohistochemistry was done using a
double staining kit PicTure (Zymed Laboratories Inc, USA),
according with the manufacturer’s instructions. Slides were
counterstained with Mayer’s hematoxylin and Clearmount
used to mount the slides. TRAP immunohystochemistry
was performed with resource to kit PicTure-MAX Polymer
(Invitrogen, USA). Slides were counterstained with Mayer’s
hematoxilin, dehydrated, mounted with Entellan (Merck,
Germany), and coverslipped.
For all sections, positive controls were made simultane-
ously. As negative controls adjacent sections were incubated:
(a) without primary antibody and (b) with rabbit/rat normal
serum (similar concentration as that of primary).
Masson Trichrome was done using a kit (Bio-Optica,
Italy), followed by dehydration and mounting.
Observation and pictures were done using optic (Olym-
pus BX41) and fluorescence microscope equipped with WB
Fluorescence cube (Olympus U-LH100HG).
2.4. Statistical Analysis. Total bone area, immature bone
area, and mature bone area were measured using Sigma
ScanPro 5 (Systat Software Inc., USA). The results, in
percentage of total bone area, mature bone, and immature
bone, were determined for each piezoelectric film in the pre-
determined areas Z1 to Z4. Capsule thickness was measured
with resource to cell∧A software (Olympus, Germany).
Normal distribution of the results was verified using the
Kolmogorov-Smirnov test, homogeneity of variance assessed
through the Levene test, and differences between groups
tested using one-way ANOVA (at a 0.05 level). The statistical
analysis was done using software OriginPro 8 (OriginLab
Corporation, USA).
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Figure 3: Low-magnification picture of histological section where it is evident the fibrous tissue around the implant (arrows). Scale bar
represents 4mm.
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Figure 4: Total bone area measured around actuators and static
controls, expressed in percentage. Bars represent means and error
bars standard deviation.
3. Results
After one-month implantation period, there were statistically
significant differences. Total bone area around the actuators
was significantly higher, when comparing to static controls
(39.91± 14.08% versus 27.20± 11.98%) (Figure 4).
The increment of bone occupied area was due to new
bone formation, and in actuators the area occupied by woven
bone and osteoid was 64.89 ± 19.32% of the total bone area
versus 31.72±14.54% in static devices (Figure 5). The chosen
staining technique, Giemsa Eosin, stains older bone in a
darker shade of pink, whilst more recently deposed bone is
of a lighter pink color and frequently adjacent to much less
prominent osteoid (dark blue) areas (Figures 5(a) and 5(b)).
Taking into account the close relation in between osteoid
and woven, recently formed bone, the authors chose not to
make separated measurements that could be misleading. The
bone marrow present in the sections showed no relevant
alterations.
The deposition of new bone was more marked in certain
areas of the devices. The significant differences arise from the
bone areas surrounding the two distal thirds of the devices;
around the devices’ clamped area, no differences were found
between actuated and static devices (Figure 6).
When assessing the mineral apposition rate in the distal
third of the films, with the aid of the fluorochrome labeling,
the mineral apposition rate was significantly higher around
actuated devices (4.44 ± 1.67µm/day) than around static
devices (2.70± 0.95µm/day) (Figure 5).
A fibrous capsule was obvious both in actuators and static
devices, with no statistical significant differences in capsule
thickness between the two groups (289.59 ± 131.20µm
in actuated films versus 293.93 ± 84.79µm). The average
thickness of the capsule was of 292 µm.
Immunohistochemistry failed to detect differences in
TRAP expression between the two groups, but there is a
marked elevation in OPN detection around actuators, in
Z3 and Z4 (Figure 7). OPN is also strongly labeled in the
fibroblast layers closer to the PVDF films, both in actuators
and static controls, and this is the area where positive PCNA
labeling was found more often. PCNA labeling was also
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Figure 5: Microphotograph of nondecalcified sections. On top, (a) shows Z3 areas of actuator and (b) shows static control, both implanted
in the same position in tibia. On bottom, Z2 areas showing increase labeled area in (c) femoral actuator when compared to contra lateral (d)
static control. A fibrous capsule (FC) was present on the bone/film interface. Scale bar represents 200 µm.
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Figure 6: Total bone area measured around actuators and static
controls, organized by areas Z1 to Z4. Bars represent means and
error bars standard deviation.
positive in some of the preosteoblastic cells in layers apposed
to OPN-positive columnar osteoblasts.
4. Discussion
The existence of micro-movements at the interface, depend-
ing on the magnitude, may enhance osteogenesis or impair
it and promote the formation of fibrous tissue [11, 12].
Considering the deformation levels of the actuator devices,
under the experimental conditions, the generated strains
were low, but the results suggest they are enough to elicit
response.
Mineral apposition rate and total bone mass are signifi-
cantly higher around actuated films when compared to static
controls, and these differences arise from around the areas of
the films known to have higher displacement values.
The increased OPN expression we found around actua-
tors when comparing to static controls is most likely asso-
ciated with mechanical stress, and it was not accompanied
by a proportional increase in TRAP. OPN is a multifunc-
tional noncollagenous glycoprotein present in bone matrix,
expressed in various degrees by proliferating preosteoblasts,
osteoblasts, and osteocytes but also by fibroblasts, osteoclasts,
and macrophages [13–15]. OPN production is known to
be increased in association with mechanical loading [15,
16], and its deficiency significantly decreases bone fracture
toughness, leading to heterogeneous mineral distribution,
since OPN is known to bind strongly to hydroxyapatite, and
cell surface as well [17, 18].
However, a few questions arise. The first is related to
PVDF’s biocompatibility. We observed that all the devices
were separated from neighboring bone by a fibrous capsule.
This is probably due to the material itself, since there were
no differences between actuators and static controls. It would
be mandatory to develop and test a material with improved
biocompatibility to evaluate accurately the bone material
interface.
One other issue arises from reflecting upon the material
and the coating properties and behavior. The in vitro study
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Figure 7: Microphotograph of decalcified sections, osteopontin (white arrows) and PCNA expression. Picture shows Z3 areas of
femoral: (a) actuator and (b) static control, suggesting more extensive osteopontin labeling around actuator. Double Fast-Red and DAB
immunohistochemistry staining for osteopontin and PCNA, respectively. Scale bar represents 100 µm.
previously developed shows evidence of adequate electric
insulation for 48 hours in the experimental conditions [10].
However, the in vivo environment is not as controlled
and, in addition to a longer period of time, the implantation
procedure itself may induce damage on the coating. If
coating damage occurs, one should consider the possible
effects of the material (PVDF and silver nitrate particles
from the electrode) and electrical current. Previous studies
have shown cytotoxic silver nitrate activity, dependent on the
concentration [19, 20].
The possible creation of electric field locally and its
effects are more complex. The clinical advantages of applying
electrical and electromagnetic fields in the treatment of
fractures and mal-unions have been long known although
the mechanisms leading to the clinical response are not
well understood [21–23]. Electric fields as low as 0.1mV/cm
promote osteoblast proliferation, with cell metabolic activity
being influenced by the intensity of the electric field, and cell
signaling based on the voltage-dependent calcium channels
[24, 25]. Electric and electromagnetic fields also exert effects
on fibroblasts, enhancing proliferation, protein synthesis
and influencing cell alignment, by calcium-independent
mechanisms [26–29]. The fact that we found no significant
differences in fibrous capsule thickness surrounding the
devices suggests it is likely that the electric insulation
remained satisfactory, but further studies would be needed
to prove this. However, if an electric field was being created
locally, increased bone formation along the whole actuator
could also be expected. Instead, new bone formation follows
a pattern in accordance with what is known to be the areas of
increased motion and deformation.
This study was performed in one animal only but using
an adequate number of devices (total of twelve). The sheep
was chosen as an animal model considering the bone biology
similarities with the human species and the size of the
devices. The results are very clear in evidencing qualitative
and quantitative statistically significant differences when
comparing static and actuated films, but it would be
necessary to enlarge the animal study and to study response
with longer implantation times. However, from an ethical
point of view, it would be desirable to do so after developing
a material other than PVDF, more biocompatible.
5. Conclusions
In conclusion, the present in vivo study suggests that in fact
piezoelectric materials and the converse piezoelectric effect
may be used to effectively stimulate bone growth at the bone
implant interface, eliciting an early response. Piezoelectric
materials have the advantages of enabling a wide range
of deformation/displacement, frequencies, and regimens.
Therefore, they are excellent candidate components of actua-
tors for clinical purposes. However, new materials should be
developed, aiming better biocompatibility.
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